BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1475272)

  • 1. In vivo and in vitro magnesium effects on aortic prostacyclin generation in DOCA-salt hypertensive rats.
    Laurant P; Moussard C; Alber D; Henry JC; Berthelot A
    Prostaglandins Leukot Essent Fatty Acids; 1992 Nov; 47(3):183-6. PubMed ID: 1475272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1-induced contraction in isolated aortae from normotensive and DOCA-salt hypertensive rats: effect of magnesium.
    Laurant P; Berthelot A
    Br J Pharmacol; 1996 Dec; 119(7):1367-74. PubMed ID: 8968545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary magnesium supplementation modifies blood pressure and cardiovascular function in mineralocorticoid-salt hypertensive rats but not in normotensive rats.
    Laurant P; Kantelip JP; Berthelot A
    J Nutr; 1995 Apr; 125(4):830-41. PubMed ID: 7722684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnesium supplementation and deoxycorticosterone acetate--salt hypertension: effect on arterial mechanical properties and on activity of endothelin-1.
    Berthon N; Laurant P; Hayoz D; Fellmann D; Brunner HR; Berthelot A
    Can J Physiol Pharmacol; 2002 Jun; 80(6):553-61. PubMed ID: 12117304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and regional hemodynamic effect of acute magnesium administration in the normotensive and hypertensive state.
    DiPette DJ; Simpson K; Guntupalli J
    Magnesium; 1987; 6(3):136-49. PubMed ID: 3626625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of endothelium on Mg(2+)-induced relaxation in noradrenaline-contracted aorta from DOCA-salt hypertensive rat.
    Laurant P; Berthelot A
    Eur J Pharmacol; 1994 Jun; 258(3):167-72. PubMed ID: 8088352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possible role of prostacyclin synthase in altered prostacyclin generation in DOCA-salt hypertensive rats.
    Uehara Y; Numabe A; Takada S; Hirawa N; Nagata T; Ishimitsu T; Sugimoto T; Yagi S
    Am J Hypertens; 1991 Aug; 4(8):667-73. PubMed ID: 1930848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of endothelium in the in vitro vasorelaxant effect of magnesium on aortic basal tension in DOCA-salt hypertensive rat.
    Laurant P; Berthelot A
    Magnes Res; 1992 Dec; 5(4):255-60. PubMed ID: 1296760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sesamin on aortic oxidative stress and endothelial dysfunction in deoxycorticosterone acetate-salt hypertensive rats.
    Nakano D; Itoh C; Ishii F; Kawanishi H; Takaoka M; Kiso Y; Tsuruoka N; Tanaka T; Matsumura Y
    Biol Pharm Bull; 2003 Dec; 26(12):1701-5. PubMed ID: 14646174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of a methionine-supplemented diet on the blood pressure of Sprague-Dawley and deoxycorticosterone acetate-salt hypertensive rats.
    Robin S; Maupoil V; Laurant P; Jacqueson A; Berthelot A
    Br J Nutr; 2004 Jun; 91(6):857-65. PubMed ID: 15182389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular eicosanoid production in experimental hypertensive rats with different mechanisms.
    Ishimitsu T; Uehara Y; Iwai J; Sugimoto T; Hirata Y; matsuoka H; Sugimoto T
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):179-84. PubMed ID: 1871182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Hydroxytryptamine lowers blood pressure in normotensive and hypertensive rats.
    Diaz J; Ni W; Thompson J; King A; Fink GD; Watts SW
    J Pharmacol Exp Ther; 2008 Jun; 325(3):1031-8. PubMed ID: 18305011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dietary magnesium on blood pressure and vascular lesions in hypertensive rats.
    Liu DT; Turner SW; Wang MX; Whitworth JA
    Pathology; 1994 Oct; 26(4):365-9. PubMed ID: 7892033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha-lipoic acid on deoxycorticosterone acetate-salt-induced hypertension in rats.
    Takaoka M; Kobayashi Y; Yuba M; Ohkita M; Matsumura Y
    Eur J Pharmacol; 2001 Jul; 424(2):121-9. PubMed ID: 11476758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations to the vascular vasodepressor prostaglandin system in DOCA-salt hypertensive rats and their enzymatic analysis.
    Uehara Y; Numabe A; Hirawa N; Ishimitsu T; Takada S; Sugimoto T; Yagi S
    J Hypertens Suppl; 1988 Dec; 6(4):S392-4. PubMed ID: 3241224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidermal growth factor: a potent vasoconstrictor in experimental hypertension.
    Florian JA; Watts SW
    Am J Physiol; 1999 Mar; 276(3):H976-83. PubMed ID: 10070082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of enalapril on the endothelial function of DOCA-salt hypertensive rats.
    Nunes VW; Fortes ZB; Nigro D; Carvalho MH; Zorn TM; Scivoletto R
    Gen Pharmacol; 2000 Feb; 34(2):117-25. PubMed ID: 10974419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphoinositide 3-kinase mediates enhanced spontaneous and agonist-induced contraction in aorta of deoxycorticosterone acetate-salt hypertensive rats.
    Northcott CA; Poy MN; Najjar SM; Watts SW
    Circ Res; 2002 Aug; 91(4):360-9. PubMed ID: 12193470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sesamin on altered vascular reactivity in aortic rings of deoxycorticosterone acetate-salt-induced hypertensive rat.
    Matsumura Y; Kita S; Ohgushi R; Okui T
    Biol Pharm Bull; 2000 Sep; 23(9):1041-5. PubMed ID: 10993201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of magnesium on mRNA expression and production of endothelin-1 in DOCA-salt hypertensive rats.
    Berthon N; Laurant P; Fellmann D; Berthelot A
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):24-31. PubMed ID: 12827022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.